The British Medical Association (BMA), the trade union representing doctors across the UK, reverses its previous stance on the Cass review of gender identity services in the NHS. Multiple outlets report that the BMA now says the review’s findings are “robust” and no longer opposes the report itself, marking a change from its earlier rejection of the Cass recommendations.
The update also comes with a continuing point of disagreement. While the BMA aligns with the overall conclusions of the Cass review, it continues to oppose the government’s proposed ban on puberty blockers. The sources present this as a distinct position from the BMA’s revised view of the evidence base described in the Cass review.
Overall, the reporting indicates that the BMA’s shift is about endorsing the Cass review’s findings rather than accepting all policy moves that may be linked to the review, particularly regarding medication used in some transgender-related care. The BMA’s decision is portrayed as a significant change in doctors’ organisational support for how gender identity services are guided in the NHS.
